A cyclotron is a particle accelerator. It is an electrically powered machine that produces beam of charged particles used for industrial, research and medical purposes. In medical applications, cyclotrons produce beams that are used to manufacture radioisotopes for the purpose of medical imaging. Various medical cyclotrons are being used for the production of SPECT and Positron Emission Tomography (PET) isotopes used for therapeutic as well as other medical applications. Cyclotrons can be used in particle therapy to treat cancer with the help of ion beams that can penetrate the body and kill the tumors with the help of radiation.
General Electric Company and IBA – Notable Market Players in Medical Cyclotron Market
The Medical Cyclotron market majorly consists of the players such as General Electric Company, Best ABT Molecular Imaging, Inc., IBA, Sumitomo Heavy Industries, Ltd., Siemens AG, Advanced Cyclotron Systems, ISOSOLUTION, ALCEN, IONETIX Corporation, and Best Cyclotron System, Inc. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized strategies such as product launches, expansions, and product upgradations for the growth of their organizations. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.
Below is the list of the growth strategies done by the players operating in the Medical Cyclotron market:
| Year | News |
| Aug-2020 | IBA is the world leader in cancer diagnostic systems and the recipient of a contract to install a Cyclone 70 system at the Institute for Basic Science in Daejeon, South Korea. The project will cost between USD 13 and USD 16 million, all of which will be financed through IBA. |
| Aug-2020 | The German health company Siemens Healthineers reported on Aug, 2020 that it will acquire Varian Medical Systems Inc. in an agreement that values the U.S. manufacturer of cancer treatment equipment and software at $16.4 billion. |
| Jan-2022 | IBA announced that it had launched a new low energy and compact size cyclotron, the Cyclone KEY. The new machine will enable small and medium-sized hospitals to produce their radiopharmaceutical products in-house while providing more widespread global access to diagnostic solutions in oncology, neurology, and cardiology. |
| Nov-2021 | IONETIX announced the FDA approval for N-13 Ammonia manufacturing at Adler Institute for Advanced Imaging in Jenkintown, PA. Adler Imaging will be using the N-13 Ammonia manufactured by IONETIX to perform Cardiac PET imaging. |
| Oct-2021 | Sumitomo Heavy Industries, Ltd. had conducted proton beam acceleration tests on its in-house developed superconducting cyclotron for the next-generation proton therapy system under development. They confirmed the generation of a high-intensity proton beam of 1,000 nA. |
| Jun-2021 | Best ABT Molecular Imaging introduced their newest Best Sub-Compact Model 200 Self-Shielded Cyclotron for producing a range of radioisotopes for Medical and Research Applications at the push of a button. This cyclotron can be installed with one or more chemistry modules next to a PETCT/PET-MRI. |
| Jun-2021 | IBA launched its new high energy and high-capacity cyclotron, the Cyclone IKON, which offers the largest energy spectrum for PET and SPECT isotopes from 13 MeV to 30 MeV. |
| Mar-2021 | IONETIX, a leading cyclotron technology, and isotope manufacturing company, has acquired a 10,300 sq. ft. facility in Lansing, MI, for its new Targeted Alpha Radionuclide Manufacturing Center. |
